USFDA14 Jun 2025, 04:26 pm
Dishman Carbogen Amcis Ltd.: US-FDA Inspection at Naroda Facility Successfully Completed Without Any Observations
AI Summary
Dishman Carbogen Amcis Ltd. has successfully completed the US-FDA inspection at its Naroda, Ahmedabad facility. The inspection, which was planned between 9th and 13th June 2025, was concluded on 12th June 2025 without any observations or issuance of Form 483's. This confirmation signifies that no concerns were discovered during the inspection. The Company's facilities at Naroda and Bavla in India, and multiple group facilities in Switzerland and the Netherlands continue to be approved by the US FDA.
Key Highlights
- US-FDA inspection at Dishman Carbogen Amcis Ltd.'s Naroda facility successfully completed
- Inspection concluded on 12th June 2025 without any observations or Form 483's
- No concerns discovered during the inspection
- Company's facilities in India, Switzerland, and the Netherlands continue to be approved by the US FDA